452
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study)

, , , , , , , , , , , , & show all
Pages 186-195 | Received 27 May 2015, Accepted 06 Jul 2015, Published online: 22 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Harpreet Singh, Liam Wilson, Tom Tencer & Jinender Kumar. (2023) Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis. ClinicoEconomics and Outcomes Research 15, pages 125-138.
Read now

Articles from other publishers (3)

Edo H J Savelkoul, Pepijn W A Thomas, Lauranne A A P Derikx, Nathan den Broeder, Tessa E H Römkens & Frank Hoentjen. (2022) Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis. Inflammatory Bowel Diseases.
Crossref
Fabio Salvatore Macaluso, Flaminia Cavallaro, Carla Felice, Marta Mazza, Alessandro Armuzzi, Paolo Gionchetti, Maurizio Vecchi & Ambrogio Orlando. (2019) Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review. Digestive and Liver Disease 51:5, pages 613-620.
Crossref
Siddharth Singh, John George, Brigid S Boland, Niels Vande Casteele & William J Sandborn. (2018) Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 12:6, pages 635-643.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.